Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era

About this episode

This episode discusses the nuances of treating extensive-stage small cell lung cancer (SCLC) and the role of immunotherapy in individualizing patient care.

Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era

People in this episode

Guests: Jonathan W. Goldman, MD, Misty Dawn Shields, MD, PhD

Topics covered

• SCLC treatment
• immunotherapy
• individualized care
• extensive-stage cancer
• clinical pharmacology

Keywords

• SCLC
• immunotherapy
• cancer treatment
• clinical pharmacology
• personalized medicine

Mentioned in this episode

Organizations: PeerVoice

More episodes of PeerVoice Clinical Pharmacology Audio

• Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic Disease · June 9, 2026 · 26 min
• David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real World · June 5, 2026 · 21 min
• Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer · June 5, 2026 · 20 min
• Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge · June 5, 2026 · 19 min
• Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer · May 26, 2026 · 54 min
• Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice · May 18, 2026 · 36 min